Breaking News

TriRx Partnership with Liverpool City Region Advances Biotech Capabilities

Investment will foster economic growth, create high-value jobs, and complement the existing Speke Biopharmaceutical cluster in the region.

TriRx Pharmaceutical Services, LLC, a contract development, and manufacturing organization (CDMO), welcomed the UK Government’s recent announcement on England’s second Investment Zone, focused on Life Sciences in the Liverpool City Region. TriRx Speke Ltd. is the first investor and is well-positioned to further advance its capabilities by adding upstream technologies to manufacture monoclonal antibodies to an existing large-scale biotech purification facility. The current facility...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters